FXCO

NASDAQ

Financial Strategies Acquisition Corp.

SectorFinanceIndustryBlank ChecksIPO2023

News25/Ratings0

Financial Strategies Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company focuses on identifying businesses in the financial technology and financial services sector. Financial Strategies Acquisition Corp. was incorporated in 2020 and is based in Dallas, Texas.

Latest news

25 items

808d13D/G
SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)
SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
885dSEC
SEC Form 25-NSE filed by Financial Strategies Acquisition Corp.
25-NSE - Financial Strategies Acquisition Corp. (0001817565) (Subject)
986dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1043dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1073dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1077dSEC
SEC Form NT 10-Q filed by Financial Strategies Acquisition Corp.
NT 10-Q - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1092dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1108dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1121dSEC
SEC Form NT 10-K filed by Financial Strategies Acquisition Corp.
NT 10-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1136dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1157d13D/G
SEC Form SC 13G filed by Financial Strategies Acquisition Corp.
SC 13G - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1161dSEC
SEC Form 425 filed by Financial Strategies Acquisition Corp.
425 - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1161dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1164d13D/G
SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)
SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1164d13D/G
SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)
SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1165dNEWS
Financial Strategies Acquisition Corp. Announces Merger With Austin Biosciences Corp, A Texas Biotechnology Platform Company; Austin Biosciences's Shareholders Will Receive An Aggregate Of 12.5M Shares Of FXCO's Class A Common Stock
Financial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company's common stock is expected to be listed on the Nasdaq Capital Market under the ticker symbol "ASTN." Austin Biosciences Corporation Highlights Austin Biosciences is a p
1165dPR
Financial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, A Texas Biotechnology Platform Company
DALLAS and AUSTIN, Texas, Feb. 13, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO) ("FXCO")(the "Company")., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. ("Austin Biosciences"). Upon closing of the transaction, Austin Biosciences will become a wholly-owned subsidiary of the Company. Mr. Schinzing will serve as Chairman and Mr. Burgi-Krishnamurthy will serve as Chief Executive Officer of Austin Biosciences. The Company'
1169dPR
Financial Strategies Acquisition Corp. Announces Extension of Termination Date and Additional Contribution to Trust Account to Extend Termination Date
DALLAS, Feb. 9, 2023 /PRNewswire/ -- Financial Strategies Acquisition Corp. (NASDAQ:FXCO, the ", Company", ))), a special purpose acquisition company, announced today that its Board of Directors (the "Board") has approved an extension of the period of time available to the Company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023 (the "Termination Date"), as permitted under the Company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the Company to complete an initial business combination.
1169dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1170d13D/G
SEC Form SC 13G/A filed by Financial Strategies Acquisition Corp. (Amendment)
SC 13G/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1172dINSIDER
SEC Form 4: Schinzing Alexander V converted options into 1,851,250 shares
4 - Financial Strategies Acquisition Corp. (0001817565) (Issuer)
1177d13D/G
SEC Form SC 13D/A filed by Financial Strategies Acquisition Corp. (Amendment)
SC 13D/A - Financial Strategies Acquisition Corp. (0001817565) (Subject)
1178dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Leadership Update
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1198dSEC
Financial Strategies Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Financial Strategies Acquisition Corp. (0001817565) (Filer)
1198dNEWS
Financial Strategies Acquisition Announces Extension Of Termination Date, Additional Contribution To Trust Account To Extend Termination Date